Top Story

JUPITER update: Percent reduction of LDL relates to magnitude of risk reduction

JUPITER update: Percent reduction of LDL relates to magnitude of risk reduction
December 1, 2015

ORLANDO, Fla. — Percent reduction of LDL is related to the magnitude of reduction of risk for first CV event observed in patients on high-intensity statin therapy, according to new findings from the JUPITER trial presented at the American Heart Association Scientific Sessions.

“These data provide general support for the concept of introducing percent reduction in LDL into broader clinical practice, an approach consistent with that being advocated by current European, Canadian and U.S. guidelines,” Paul M. Ridker, MD, MPH, said during a presentation.

In the Journals

Air pollution increases CVD risk in women with diabetes

December 1, 2015
Women with diabetes exposed to long-term traffic pollution have a 44% increased risk for cardiovascular disease and a 66% increased risk for stroke, according to…
Meeting News Coverage

PARTNER II Valve-in-Valve registry suggests alternative to reoperation in failed aortic bioprostheses

November 30, 2015
Valve-in-valve transcatheter valve replacement using Sapien XT appears to be a valuable alternative to reoperation in patients with failed aortic bioprostheses…
FDA News

FDA approves rosuvastatin for use in youth aged 8 to 17 with HeFH

November 30, 2015
AstraZeneca announced that the FDA has approved rosuvastatin to reduce total cholesterol, LDL and apolipoprotein B in pediatric patients aged 8 to 17 years with…
SupplementPublication Exclusive

Research highlights progress of PROMISE, controversies in treatment of chronic angina

Cardiology Today, November 2015
New-onset stable chest pain or angina in those without diagnosed heart disease affects about 4 million Americans per year. In response, the editors of Cardiology
More News Headlines »

The Patient With Atrial Fibrillation

No commercial support for this activity.

Atrial fibrillation is the most common type of tachyarrhythmia and is characterized by disorganization of the heart’s…
More »
Meeting News Coverage Video

VIDEO: Liraglutide fails to improve HF outcomes in FIGHT trial

November 28, 2015
More »

The Patient with Coronary Artery Disease and an Acute Ischemic Stroke

No commercial support for this activity.

Patients with hypertension, coronary artery disease, systemic atherosclerosis and heart failure are at increased risk…
More »